GB001

· GB001, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GB001, covering 2021-07-30 to 2021-08-23. Get the full timeline:

Most recent: Clinical Trial Update: GB001 in Adult Subjects With Moderate to Severe Asthma [Phase 2]